Enzyme responsive mesoporous silica nanoparticles for targeted tumor therapy in vitro and in vivo.
about
Surface Modified Multifunctional and Stimuli Responsive Nanoparticles for Drug Targeting: Current Status and UsesControlled actuation of therapeutic nanoparticles: an update on recent progressCurrent Multistage Drug Delivery Systems Based on the Tumor Microenvironment.Stimuli-responsive nanoparticles for targeting the tumor microenvironment.Development of mesoporous silica-based nanoparticles with controlled release capability for cancer therapy.Drug "Pent-Up" in Hollow Magnetic Prussian Blue Nanoparticles for NIR-Induced Chemo-Photothermal Tumor Therapy with Trimodal Imaging.Mesoporous silica nanoparticles for stimuli-responsive controlled drug delivery: advances, challenges, and outlookIntracellular pH-responsive and rituximab-conjugated mesoporous silica nanoparticles for targeted drug delivery to lymphoma B cellsEstradiol shows anti-skin cancer activities through decreasing MDM2 expression.Intracellular delivery of nanocarriers and targeting to subcellular organelles.Mesoporous silica nanoparticles in tissue engineering--a perspective.Stimuli-responsive dendrimers in drug delivery.Advances in Peptide Functionalization on Mesoporous Silica Nanoparticles for Controlled Drug Release.Matrix metalloproteases-responsive nanomaterials for tumor targeting diagnosis and treatment.pH-Responsive Mesoporous Silica and Carbon Nanoparticles for Drug Delivery.Mesoporous Silica and Organosilica Nanoparticles: Physical Chemistry, Biosafety, Delivery Strategies, and Biomedical Applications.A Hyaluronidase-Responsive Nanoparticle-Based Drug Delivery System for Targeting Colon Cancer Cells.Polyarginine and PEG-AEYLR comodified nanostructured lipid carrier: 10mol% uncleavable PEG-AEYLR showed no shielding effect to polyarginine in vitro while maintaining good tumor targeting in vivo.An NAD(P)H:quinone oxidoreductase 1 (NQO1) enzyme responsive nanocarrier based on mesoporous silica nanoparticles for tumor targeted drug delivery in vitro and in vivo.A redox-responsive mesoporous silica nanoparticle with a therapeutic peptide shell for tumor targeting synergistic therapy.The Current Role of Cell-Penetrating Peptides in Cancer Therapy.pH sensitive chitosan-mesoporous silica nanoparticles for targeted delivery of a ruthenium complex with enhanced anticancer effects.Synthesis and Application of Dendritic Fibrous Nanosilica/Gold Hybrid Nanomaterials.Mesoporous-Silica-Functionalized Nanoparticles for Drug DeliveryStimuli-responsive delivery vehicles based on mesoporous silica nanoparticles: recent advances and challengesBismuth ferrite-based photoactive materials for the photoelectrochemical detection of disease biomarkers coupled with multifunctional mesoporous silica nanoparticlesIntegration of polymers in the pore space of mesoporous nanocarriers for drug deliveryMesoporous Silica Nanoparticles: A Comprehensive Review on Synthesis and Recent AdvancesMesoporous silica materials for controlled delivery based on enzymesTumor Microenvironment Targeted Nanotherapy
P2860
Q28071773-C531FC85-07A3-4A10-89BA-256BEF33D5B8Q28077645-B2050E9A-438C-4B08-8A3B-F13366B15396Q30362001-4CC82110-3907-47FB-8FF1-037046337C93Q36307519-5BC6CF46-8E2B-4900-B7EB-3EFAC9600EF0Q36328315-D643B184-E082-4C47-84B3-326CA8E54AACQ36361055-B4474682-D725-45A4-AB50-6954AF977E77Q37538055-C1F11565-9919-4F24-8B03-859DD17811B2Q37625848-8FAEDF20-594E-4495-98CB-B800AAD93D3EQ37702737-1C45CFB6-6B69-4E5B-8F8C-C93FD8084359Q38584491-83223A6A-0F99-42E1-A7D6-3F77539AA4C5Q38702716-20A94BAB-E386-4C8A-8BD4-40DC439C8A15Q38710183-F1C4A759-BBCE-4DBE-86DC-3E6DA0DCA544Q38827516-6640ABBB-55DD-4EE1-8B54-1F2F7C6823FCQ39375298-E5D71A6A-F3EB-4F2B-A4F6-031D72DD2F3EQ41512962-EF5017F9-AB6B-40A1-B72E-7246A8D38E00Q47295411-FD16F7FE-8EC6-4418-A65F-2DFE9B102404Q48039277-0469589A-913A-4FEC-80C2-073FDC7CEC42Q50765370-D3B9F2C6-FEF1-4622-AD8F-80F37F38592AQ51301248-D6AFE513-619E-41F8-A48B-CD4B41A5AB43Q51778366-FAFA9E3A-5897-42F5-BCB0-6453326844A3Q52450404-0851704B-ED26-4592-97CA-E7906D9F7EF2Q52860099-205714C0-88EE-4422-A072-53E55BA35CD9Q54947858-23C2B22F-81BF-435A-A632-CC94F0DCA04AQ57342490-5A1CB984-EBC2-4A49-BF44-07994E4DCDACQ57367589-A4BFB271-D98C-4F01-873A-93BD3B274022Q57368228-FAB83D57-7EAD-45D5-A8A3-EC84AC815473Q57368237-F2EDB587-9EE9-4C34-B0E2-947A7E3F7153Q57372130-F8BF2820-929F-4BC8-8475-91A41FD2E439Q57401048-1722F857-B549-4BE1-B34D-30BD713E8C28Q59133567-99A25AC2-291F-4329-BA17-E8D2290318CF
P2860
Enzyme responsive mesoporous silica nanoparticles for targeted tumor therapy in vitro and in vivo.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Enzyme responsive mesoporous s ...... therapy in vitro and in vivo.
@en
type
label
Enzyme responsive mesoporous s ...... therapy in vitro and in vivo.
@en
prefLabel
Enzyme responsive mesoporous s ...... therapy in vitro and in vivo.
@en
P2093
P2860
P356
P1433
P1476
Enzyme responsive mesoporous s ...... therapy in vitro and in vivo.
@en
P2093
Beilu Zhang
Jinghua Li
Junjie Liu
Kaiyong Cai
Liangliang Dai
Xiaojing Zhao
Xingwei Ding
P2860
P304
P356
10.1039/C5NR00072F
P407
P577
2015-02-01T00:00:00Z